The sixth company to come out ophthalmology incubator ForSight Labs said today that it raised $3.0 million from a syndicate of nine unnamed investors. Stealthy ForSight Vision6 revealed the equity round in a regulatory filing today. The company added $3.0 million in December 2014 to the $1 million is raised in 20153 from a lone backer. […]
Allergan picks up ForSight Vision for $95m
Allergan (NYSE: AGN) said today it inked a deal to buy drug-eluting ophthalmological implant maker ForSight Vision5 for $95 million up front, with a possible milestone payment for launching its drug-eluting device. Pharmaceutical giant Allergan said the device, known as the Helios ring, is designed for extended drug delivery and for reducing intraocular pressure in […]
ForSight Vision5’s Helios implant delivers at 6 months in Phase II trial
The Helios drug-eluting implant developed by ForSight Vision5 lowered intraocular pressure in glaucoma patients by about 20% after 6 months, according to study results published today in Ophthalmology, the journal of the American Academy of Ophthalmology. The Helios device is a thin, silicone ring impregnated with the glaucoma drug bimatoprost that’s designed to slowly release the drug […]
ForSight Vision5 adds another $8m
ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said today that it raised another $7.8 million. ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments. Last year the company reeled in a $15 million Series C round. […]
Stealthy ForSight Vision6 raises another $3m
The 6th company to come out ophthalmology incubator ForSight Labs said this month that it raised $3.0 million from a syndicate of 5 unnamed investors.
Stealthy ForSight Vision6 revealed the equity round in a Dec. 6 regulatory filing.
GI Dynamics raises $32M in private placement with group overseas | Medtech funding stories for the week of May 5, 2014
ForSight moves on to VISION6 with $6M equity funding round
California ophthalmic incubator ForSight Labs is seeking $6 million in order to fund its VISION6 project, the latest in a string of developments spun out of the company.
ForSight Vision5 pulls down a $15 million Series C round | Medtech funding stories for the week of Apr. 21, 2014
ForSight Vision5 lands $15M Series C round
ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said it pulled down a $15 million Series C round.
ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments.
ForSight Vision5 gets new CEO, closes $9.3M funding round
ForSight Vision5, an early-stage ophthalmology company based in Silicon Valley, named venture capitalist and medtech veteran John Maroney as its new chief executive.
Wright Medical announces $200M debt offering | Wall Street Beat
Wright Medical (NSDQ:WMGI) said it’s planning a private placement for $200 million worth of senior notes due 2017.
